Administration and monitoring of nitric oxide in ex vivo fluids

1. A method of monitoring nitric oxide administration to blood circulating in an extracorporeal oxygenation (ECMO) circuit for biological material preservation comprising: oxygenating the blood via a membrane oxygenator; administering nitric oxide to the oxygenated blood comprising red blood cells by contacting the blood with a gas comprising a nitric oxide delivery concentration in a range from 1 ppm to 300 ppm; monitoring, via a monitoring device, methemoglobin levels in the blood; decreasing the nitric oxide delivery concentration administered in a case where the methemoglobin levels meet or exceed 12% as a percentage of methemoglobin relative to the red blood cells.

2. The method of claim 1 , wherein the biological material comprises one or more of isolated cells, tissue, a partial organ or a complete organ.

3. The method of claim 2 , wherein the partial organ or the complete organ comprises one or more of a heart, lung, kidney, liver, pancreas, eye, bone, skin, heart valve, bowel, tendon, ligament or vein.

4. The method of claim 1 , wherein decreasing the nitric oxide delivery concentration comprises adjusting the flow of the gas comprising nitric oxide.

5. A system for delivering and monitoring nitric oxide in blood circulating in an extracorporeal oxygenation (ECMO) circuit, the system comprising: a membrane oxygenator; a nitric oxide delivery device operably connected to the membrane oxygenator such that oxygen and nitric oxide from a nitric oxide source are administered to blood circulating in the ECMO circuit by contacting the blood with oxygen and a gas comprising a nitric oxide delivery concentration in a range from 1 ppm to 300 ppm; and a monitoring device for monitoring methemoglobin levels in the blood, wherein the monitoring device is in communication with the nitric oxide delivery device and the nitric oxide delivery device is configured to decrease the nitric oxide delivery concentration administered in a case where the methemoglobin levels meet or exceed 12% as a percentage of methemoglobin relative to the red blood cells.

6. The system of claim 5 , wherein the monitoring device comprises one or more of a pulse oximeter or an optical measurement device.

7. The system of claim 5 , wherein the nitric oxide delivery device is in communication with a first pressure sensor and a second pressure sensor in the extracorporeal oxygenation (ECMO) circuit that provide a first pressure reading and a second pressure reading, respectively, wherein the nitric oxide delivery device compares a differential between the first pressure reading and the second pressure reading to a pressure drop threshold, and wherein the nitric oxide delivery device adjusts, when the differential is equal to or greater than the pressure drop threshold, the nitric oxide administration based on the differential between the first pressure reading and the second pressure reading.

8. The system of claim 7 , wherein the nitric oxide delivery device increases the nitric oxide administration it the differential between the first pressure reading and the second pressure reading is greater than 1% of the first pressure reading.

9. The system of claim 5 , wherein the nitric oxide delivery device is further configured to adjust the flow rate of the gas comprising nitric oxide.

10. The system of claim 5 , wherein the monitoring device is part of or integrated into the nitric oxide delivery device.

11. The system of claim 5 , wherein the nitric oxide delivery device includes a pump, an injector, or a metering device.

12. The system of claim 5 , wherein the gas comprising nitric oxide further comprises an inert diluent gas.